VOLTAGE-GATED ION CHANNEL MUTANTS FOR USE IN IDENTIFYING ION CHANNEL MODULATING COMPOUNDS
    65.
    发明申请
    VOLTAGE-GATED ION CHANNEL MUTANTS FOR USE IN IDENTIFYING ION CHANNEL MODULATING COMPOUNDS 审中-公开
    用于识别离子通道调制化合物的电压离子通道

    公开(公告)号:US20090053721A1

    公开(公告)日:2009-02-26

    申请号:US12188899

    申请日:2008-08-08

    申请人: David Fedida

    发明人: David Fedida

    摘要: The present invention provides novel methods and compositions for identifying ion channel modulating compounds, including atrial-selective antiarrhythmic agents and ion channel modulating compounds that preferentially modulate K+ channels. The ion channel modulating compounds identified according to these methods are associated with a reduced incidence of ventricular proarrhythmia.

    摘要翻译: 本发明提供用于鉴定离子通道调节化合物的新颖方法和组合物,包括优先调节K +通道的心房选择性抗心律失常药和离子通道调节化合物。 根据这些方法鉴定的离子通道调节化合物与心室心律失常的发生率相关。

    CONTROLLED RELEASE TABLET FORMULATIONS FOR THE PREVENTION OF ARRHYTHMIAS
    66.
    发明申请
    CONTROLLED RELEASE TABLET FORMULATIONS FOR THE PREVENTION OF ARRHYTHMIAS 审中-公开
    控制释放片剂制剂用于预防ARRHYTHMIAS

    公开(公告)号:US20090041841A1

    公开(公告)日:2009-02-12

    申请号:US12184950

    申请日:2008-08-01

    IPC分类号: A61K31/4015 A61K9/22 A61P9/06

    摘要: Methods, formulations, dosing regimes, and routes of administration for the treatment or prevention of arrhythmias, including the treatment or prevention of atrial fibrillation are disclosed. Controlled release tablet formulations comprising a therapeutically effective amount of an ion channel modulating compound, or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients suitable for controlled release formulations are disclosed. In these methods, the disease or condition is treated or prevented by administering one or more ion channel modulating compounds to a subject, where the ion channel modulating compound or compounds produce specific plasma levels in the subject. The ion channel modulating compounds may be cycloalkylamine ether compounds, particularly cyclohexylamine ether compounds.

    摘要翻译: 公开了用于治疗或预防心律失常的方法,制剂,给药方案和给药途径,包括治疗或预防心房颤动。 公开了包含治疗有效量的离子通道调节化合物或其药学上可接受的盐和一种或多种适用于控制释放制剂的药学上可接受的赋形剂的控释片剂。 在这些方法中,通过向受试者施用一种或多种离子通道调节化合物来治疗或预防疾病或病症,其中离子通道调节化合物或化合物在受试者中产生特异性血浆水平。 离子通道调节化合物可以是环烷基胺醚化合物,特别是环己胺醚化合物。

    Dosing Regimens For Ion Channel Modulating Compounds
    68.
    发明申请
    Dosing Regimens For Ion Channel Modulating Compounds 有权
    离子通道调节化合物的给药方案

    公开(公告)号:US20080171785A1

    公开(公告)日:2008-07-17

    申请号:US11667139

    申请日:2005-11-08

    IPC分类号: A61K31/40

    CPC分类号: A61K31/40

    摘要: Dosing regimens, routes of administration and methods for the treatment or prevention of arrhythmias are disclosed. In these methods, arrythmias (e.g. atrial fibrillation, atrial flutter, early after depolarizations and prolongation of QT interval) may be reduced or eliminated by administering ion channel modulating compounds to a subject in need thereof via the dosing regimens disclosed herein.

    摘要翻译: 公开了给药方案,给药途径和治疗或预防心律失常的方法。 在这些方法中,可通过经由本文公开的给药方案向有需要的受试者施用离子通道调节化合物来减轻或消除心律失常(例如心房扑动,去极化后早期和延长QT间期)。